INSTRUCTIONS FOR APPLICANTS 
All applications must be signed by the candidate, Sponsor and official authorized 
to sign for the sponsoring institution. 
All applications pertaining to human research must have the written approval of 
the sponsoring institution's Council on Human Investigation and those which do not 
deal with human research must so state. (See "Terms of the Grants", paragraph seven 
for statement required.) 
All applications covering research projects which may involve biohazards for the 
investigator, other personnel, or any other individuals must include a description 
of the safeguards planned. 
Only one application in each category (Scholar, Special Fellow or Fellow) from an 
individual Sponsor will be considered. 
Leukemia Society of America awards cannot be used to supplement other special awards 
given to an individual; that is, a Leukemia Society of America grant cannot be held 
concurrently with another grant which provides a higher level of funding. Leukemia 
Society awards may, however, be supplemented from other sources. 
A statement must be made in the application concerning the relevance of the 
proposed work to the field of leukemia and related diseases. 
38 copies of the completed application, signed by the applicant and signed and 
approved by the Sponsor and authorized official for the sponsoring institution, 
together with supporting data and letters of reference as requested in the application 
form, plus three copies of all publications pertaining to the proposed research 
project, must be sent to the Vice President, Medical and Scientific Affairs, 
Leukemia Society of America, Inc., 211 East 43rd Street, New York, New York 10017, 
on or before October 1. The Medical and Scientific Advisory Committee, which meets 
once during each fiscal year ending June 30 for this purpose, will review all 
applications. 
Within a month following the review, which usually takes place at a special session 
in January, those who have been chosen as Grantees will be so notified, and a contract 
of agreement forwarded to them, their Sponsors and their respective sponsoring in- 
stitution for signature. Funding will begin on July 1 of the same yaar with payments 
made semi-annually (or monthly in the case of foreign Grantees) to the Controller 
or other financial officer of the institution. The institution will in turn 
disburse the funds to the Grantee during the term of the grant in accordance with 
the budget submitted with the application. 
Applicants are required to use only the forms supplied by the Leukemia Society of 
America, Inc. to apply for a grant. All sections — pages one through six — must 
be completed as indicated on the official application blanks. 
Incomplete applications as well as those received after the October 1 deadline will 
be considered invalid. 
[ 211 ] 
